Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer

INTRODUCTION: The introduction of targeted drugs has had a significant impact on the approach to assessing tumour response. These drugs often induce a rapid cytostatic effect associated with a less pronounced and slower tumoural volume reduction, thereby impairing the correlation between the absence...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Nucl Med Mol Imaging
Autori principali: Woff, Erwin, Hendlisz, Alain, Garcia, Camilo, Deleporte, Amelie, Delaunoit, Thierry, Maréchal, Raphaël, Holbrechts, Stéphane, Van den Eynde, Marc, Demolin, Gauthier, Vierasu, Irina, Lhommel, Renaud, Gauthier, Namur, Guiot, Thomas, Ameye, Lieveke, Flamen, Patrick
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4969337/
https://ncbi.nlm.nih.gov/pubmed/27072811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-016-3365-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi